DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, today announced it will open its first DS Laboratories Hair Loss Clinic in Miami, Florida.
Slated to open in the fourth quarter of 2014, the clinic will provide unique therapies and treatment options for patients who desire the most comprehensive approach to treating hair loss.
A team of healthcare professionals led by a medical doctor will provide customized solutions with the most advanced proven technologies developed through DS Healthcare’s clinical research to restore a full head of hair.
“We believe no other company offers the kind of comprehensive hair loss treatment and expertise that will be delivered to patients at our DS Laboratories Hair Loss Clinic.
Our commitment to innovation has created a growing portfolio of therapies that are not available anywhere else. The clinics are the ideal platform for DS Healthcare to utilize treatment protocols accumulated through years of clinical research.
The clinics will leverage the brand awareness of DS Healthcare with an established target customer base,” stated DS Healthcare President and CEO Daniel Khesin.
According to the Washington Post Americans spend $3.5 billion per year in an attempt to treat hair loss.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects.
For more information on DS Healthcare Group’s flagship brand, visit www.dslaboratories.com
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
“Forward-looking statements” describe future expectations, plans, results, or strategies, and are generally preceded by words such as “future,” “plan” or “planned,” “expects,” or “projected.” These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations.
These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
DS Healthcare Group to Open its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies for Hair Loss